Table 3.

Demographic and disease-related data for two study groups.

	Medialization	Reinnervation
N	12	12
Age, median	57	53
Range	36 – 83	44 – 68
Female : Male	8 : 4	5 : 7
Side left : right	6 : 6	9 : 3
Site of Lesion
Proximal (%)	2 (17)	2 (17)
Middle	3 (25)	1 (8)
Distal	6 (50)	4 (33)
Unknown	1 (8)	5 (42)
ACE-27 comorbidity score
0 (no comorbid.)	3 (25)	6 (50)
1 (mild comorbid.)	4 (33)	3 (25)
2 (moderate comorbid.)	5 (42)	3 (25)
3 (severe comorbid.)	0	0
Pre-Rx voice quality
“Good” : “Bad”	7 : 5	5 : 7
Mean G+B†	3.55	3.50
Months since onset, median*	7.2	18.3
Range	1.3 – 51.8	7.9 – 144.6
Smoker current / former	2 / 4	2 / 5
Class V EMG	4	3
MPT, median (seconds)	4.7	4.4
Range	1.8 – 25.4	2.1 – 11.8

^†Mean G+B is sum of G (grade) and B (breathiness) GRBAS subscores.

^*This is the only pre-treatment parameter in which where ML and LR groups were significantly different from each other (p=0.023)